info iconCurrently, the share price for Lupin Ltd. is delayed.

close icon
Lupin Ltd. Logo

Lupin Ltd.

--   ( -- %) 1D

  • Prev. Close
  • Upper Circuit
  • Lower Circuit

Analyst Recommendations For Lupin Ltd.

Info icon
As recommended by 10 analysts


Lupin Ltd.'s Info & Management

Incorporated in 1983, Lupin Limited operates as a pharmaceutical company headquartered in Mumbai, India. It focuses on producing, developing, and marketing various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) worldwide.

Business Segment

The company’s business segments include: 

  • Key Theraputic Areas: Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives, Nonsteroidal Anti-Inflammatory Drugs, Anti-TB, and Cephalosporins
  • Biosimilar Products: offer Filgrastim, Peg-Filgrastim, and Etanercept. Notable diabetes brands include ONDERO and Gluconorm-G
  • Manufacturing Facilities: across India, the United States of America, Mexico, and Brazil

Geographical Presence

It serves both within and outside India. It engages in trading and related activities, extending its reach to global markets.

  • Company Secretary,Compliance Officer
    R V Satam
  • Executive Director,Chief Executive Officer
    Vinita Gupta
  • Executive Director,Global Chief Financial Officer,Head(Corporate Affairs)
    Ramesh Swaminathan
  • President(Novel Drug Discovery & Development)
    Dr. Rajender Kamboj
  • President(API & Global TB.)
    Mr. Naresh Gupta
  • President(India Region Formulations)
    Mr. Rajeev Sibal

FAQs on Lupin Ltd.

What is the share price of Lupin Ltd.?

Lupin Ltd. share price is ₹1,603.65 as of April 22, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Lupin Ltd.?

The 52-week high and low of Lupin Ltd. is ₹1,704.25 and ₹680.00 respectively as of April 22, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Lupin Ltd.?

The trailing twelve month (TTM) PB ratio of Lupin Ltd. is 5.90 as of April 22, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Lupin Ltd.?

The Upper Circuit of Lupin Ltd. is ₹1,702. The Lower Circuit of Lupin Ltd. is ₹1,393.

What is the ROE of Lupin Ltd.?

Lupin Ltd. reported an ROE of 3.45% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Lupin Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Lupin Ltd., Promoter held 47%, the FII held 18.3%, DII held 27.8% and the public held 6.9% of the total shares.

How to buy Lupin Ltd. Share?

You can easily buy shares of Lupin Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Lupin Ltd.?

The fair value of Lupin Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer